30 closest matches · ranked by relevance
Abortion Early
Primary: Pain VAS Score — 75; 60; 55 score on a scale
Pain Acute · Acupuncture
Primary: Visual Analog Scale for Pain (VAS Pain) Score - Acupuncture Versus Routine Care — 39.5; 71.0 score on a scale
Breast Cancer
Primary: Change From Baseline in Mean Weekly HFS Score Between Acupuncture and Usual Care Arms at the End of Week 10 — -5.3; -0.5 HFS score on a scale — p=0.0003
Posttraumatic Stress Disorder
Primary: Change in PTSD Symptom Severity on the Clinician Administered PSTD Scale - CAPS 5 From Before to After Treatment — 22.6; 29.1 score on a scale
ACL · ACL Injury · Anterior Cruciate Ligament Injury
Primary: Bang Blinding Index (BI) — 0.2; 0.11 score on a scale
Chronic Low-back Pain
Primary: Change in Back-related Disability at 6-month Post Randomization (Continuous) — -2.1; -3.1; -3.6 change in score from baseline on scale — p=.024
Colles´ Fracture · Radius Fracture
Primary: Patient-Rated Wrist Evaluation (PRWE) — 30.5; 15.2 units on a scale
Dry Eye Syndromes
Primary: Ocular Surface Disease Index : OSDI — -17.61; -17.20 Scores on the OSDI score
Thyroid or Parathyroid Surgery
Primary: Reduced Pain Medication Requirement — 5.43; 7.36 mg of Morphine
Evoked Potentials · Healthy Volunteers
Primary: Latencies of Auditory Evoked Potentials — 255; 255 ms
Persian Gulf Syndrome
Primary: SF-36P — 73.7; 64.3 units on a scale — p=0.03
Delirium in Old Age
Primary: Number of Delirium-free Days During the 7 Days of Evaluation — 5.5; 0 days — p=<0.001
Chronic Post-traumatic Headache · Mild Traumatic Brain Injury
Primary: Change in Number of Headache Days — -8; -6 headache days
Chronic Pain · Osteoarthritis · Neck Pain
Primary: Pain Interference as Measured by the Brief Pain Inventory (BPI) (Intent to Treat Model) — 6.0; 6.1; 5.1; 4.8 Units on a Scale — p=0.0691
Delirium · Respiratory Depression · Overmedication
Primary: Success of Blinding — 1; 1 Participants
Pain
Primary: Number of Participants With a Decrease in Pain Level — 18; 16 Participants
Urinary Incontinence
Primary: Percent Change in Incontinent Episodes — -38.26; -15.29 percent change in incontinent episodes — p=0.02
Allergic Rhinitis
Primary: Change in Visual Analog Scale (VAS) From Baseline to 6 Weeks (6-week Value Compared to Baseline Value) — -8; -2 Scale points
COPD Exacerbation
Primary: Dyspnea Intensity — 8.0; 6.5; 7.75; 5 units on a scale
Age-related Macular Degeneration · Stargardt Disease · Macular Dystrophy
Primary: Change on Visual Acuity (VA) of the Treated Eyes From Baseline to the End of the Study — 36; 16; 4 Eyes
Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Primary: Proportion of Responders at the End of 8-week — 60.6; 36.8 percentage of participants
Opioid Dependency
Primary: Percent of Participants Using Drugs — 35; 77 percent
Parkinsons Disease
Primary: Change in the Modified Fatigue Impact Scale Total (MFIS) Between Treatment Groups — -13.2; -16.0 units on a scale
Chronic Heart Failure
Primary: Change in Cardiac Function: LVEF — 36.14; 36.11; 40.59 LVEF Percentage — p=0.063
Breast Cancer · Head and Neck Cancer · Lymphedema
Primary: Change From Baseline in Patient-specified and Reported Symptoms on the Measure Yourself Medical Outcome Profile (MYMOP) — 1.51 units on a scale — p=<0.001
Lymphoma · Myeloma · Peripheral Neuropathy
Primary: Mean Neuropathy Severity Score (FACT-GOG-Ntx Total Score Assessment) — 20.8; 16.7; 9.9; 13.2 units on a scale
Long COVID · Pain
Primary: Pain, Enjoyment and General Activity (PEG) — 6.74; 6.74; 8.33; 9.33 Score
Post-operative Pain · Gynecological Surgery · Acupuncture
Primary: Morphine Equivalent Usage While in the Hospital — 29.59; 30.82; 10.54; 11.74 mg
Constipation
Primary: Change of the SBMs From Baseline at Week 4 — 2.7; 2.7; 2.2; 2.4 times per week — p=0.352
Obesity
Primary: Weight Change — 7; 15.1 pounds